Last reviewed · How we verify

NCT05799729

Effect of Ketamine Infusion on BIS Values

Completed Last updated 19 October 2023
What this trial tests

trial testing Ketamine in Anesthesia Brain Monitoring in 40 participants. Completed in 30 September 2023.

Timeline
1 April 2023
Primary endpoint
30 September 2023
30 September 2023

Quick facts

Lead sponsorUniversity of Padova
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date1 April 2023
Primary completion30 September 2023
Estimated completion30 September 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Padova

Who can join

Adults 18 to 90, female only, with Anesthesia Brain Monitoring or Ketamine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of this trial is to define if Concentration at the effector site (Ce) of Ketamine, during a continuous infusion and calculated with DOMINO model infusion pump are correlated with Bispectral Index BIS values during general anaesthesia for breast surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ketamine

Trials testing the same drug.

Other recruiting trials for Anesthesia Brain Monitoring

Currently open trials in the same condition.

Other University of Padova trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05799729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing